Evidence map›Paper›PMID 33315066›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2021

Understanding Drivers of Coronavirus Disease 2019 (COVID-19) Racial Disparities: A Population-Level Analysis of COVID-19 Testing Among Black and White Populations.

Aaloke Mody, Kristin Pfeifauf, Cory Bradley, Branson Fox, Matifadza G Hlatshwayo, Will Ross, Vetta Sanders-Thompson, Karen Joynt Maddox, Mat Reidhead, Mario Schootman and 2 more

Abstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Graphical displays and related statistical measures of health disparities between groups in complex sample surveys.Journal of the Royal Statistical Society. Series A, (Statistics in Society) · 2025
    Article
  8. Racial and Ethnic Disparities in COVID-19 Treatments in the United States.Journal of racial and ethnic health disparities · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Aaloke ModyWashington University School of Medicine, St Louis, Missouri, USA.ORCID 0000-0003-3787-365X
Kristin PfeifaufWashington University School of Medicine, St Louis, Missouri, USA.
Cory BradleyWashington University School of Medicine, St Louis, Missouri, USA.
Branson FoxWashington University School of Medicine, St Louis, Missouri, USA.
Matifadza G HlatshwayoWashington University School of Medicine, St Louis, Missouri, USA.
Will RossWashington University School of Medicine, St Louis, Missouri, USA.
Vetta Sanders-ThompsonBrown School of Social Work, Washington University in St Louis, St Louis, Missouri, USA.
Karen Joynt MaddoxWashington University School of Medicine, St Louis, Missouri, USA.
Mat ReidheadHospital Industry Data Institute, Missouri Hospital Association, St Louis, Missouri, USA.
Mario SchootmanSSM Health, St Louis, Missouri, USA.
William G PowderlyWashington University School of Medicine, St Louis, Missouri, USA.
Elvin H GengWashington University School of Medicine, St Louis, Missouri, USA.

Funding

Washington University Institute of Clinical and Translational Sciences (KL2) KL2TR002346 · NCATS · WASHINGTON UNIVERSITY · PI Dominic N Reeds · 2017 to 2026
$14.0M
NCATS NIH HHS KL2 TR002346NCATS NIH HHS TR002346
6 · The paper itself

Abstract

backgroundDisparities in coronavirus disease 2019 (COVID-19) testing-the pandemic's most critical but limited resource-may be an important but modifiable driver of COVID-19 inequities.

methodsWe analyzed data from the Missouri State Department of Health and Senior Services on all COVID-19 tests conducted in the St Louis and Kansas City regions. We adapted a well-established tool for measuring inequity-the Lorenz curve-to compare COVID-19 testing rates per diagnosed case among Black and White populations.

resultsBetween 14/3/2020 and 15/9/2020, 606 725 and 328 204 COVID-19 tests were conducted in the St Louis and Kansas City regions, respectively. Over time, Black individuals consistently had approximately half the rate of testing per case than White individuals. In the early period (14/3/2020 to 15/6/2020), zip codes in the lowest quartile of testing rates accounted for only 12.1% and 8.8% of all tests in the St Louis and Kansas City regions, respectively, even though they accounted for 25% of all cases in each region. These zip codes had higher proportions of residents who were Black, without insurance, and with lower median incomes. These disparities were reduced but still persisted during later phases of the pandemic (16/6/2020 to 15/9/2020). Last, even within the same zip code, Black residents had lower rates of tests per case than White residents.

conclusionsBlack populations had consistently lower COVID-19 testing rates per diagnosed case than White populations in 2 Missouri regions. Public health strategies should proactively focus on addressing equity gaps in COVID-19 testing to improve equity of the overall response.

Indexed as

COVID-19Black or African AmericanCOVID-19 TestingHumansPandemicsSARS-CoV-2COVID-19 testinginequityLorenz curveracial disparitiesstructural racism

Identifiers

PMID33315066
PMCPMC7799327

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.